<i><scp>EVI</scp>1</i>, a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinoma
Kohichiroh Yasui(Kyoto Prefectural University of Medicine), Yoshito Itoh(Fukui-ken Saiseikai Hospital)
Cited by 22
Related Papers
The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
|Oncology Reports|2017|145
Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma
|International Journal of Oncology|2018|82
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
|BMC Medical Genetics|2012|41